||Abpro is focused on a proprietary technology platform that allows for faster, more efficient production of recombinant proteins and antibodies.
is developing contrast agents for ultrasound,
computerized tomography, and magnetic resonance
imaging using synthetic polymer microencapusulation
Magnetics, Inc. designs, develops and manufactures
contrast agents for Magnetic Resonance Imaging
||Agenus is focused on the research, development, and commercialization of vaccines and vaccine adjuvants. Agenus was formerly known as Antigenics.
Technologies is a global, diversified technology
company focusing on high-growth markets in the communications,
electronics, life sciences and healthcare industries.
||Avaxia Biologics is focused on the research and development of antibody products for diseases of the GI tract.
||Concert Pharmaceuticals is focused on the research and development of novel drugs using deuterium instead of hydrogen which results in altered physiochemical and biological properties of the drug.
Pharmaceuticals, Inc. is a drug company focused
on the discovery, development and commercialization
of novel drugs to treat infections.
||Curis is a focused on its signaling pathway drug technologies to identify targeted small molecule drug candidates for cancer.
||Predictive Biosciences is focused on the development and commercialization of diagnostics to direct cancer therapy.
||Promedior is focused on the discovery and development of drugs to treat fibrotic, inflammatory and autoimmune diseases.
||Quanterix is focused on utilizing its proprietary Single Molecule Array (SiMoA™) technology for the development and commercialization of diagnostic tests utilizing human blood.
||Synageva is focused on the research and development of treatments for patients with rare diseases.
||Synta Pharmaceuticals is focused on the discovery, research, and development of small molecule drugs with a focus on cancer and chronic inflammatory diseases.
|| Taris Biomedical is a focused on the research and development of therapeutics which take advantage of local sustained delivery of therapeutics to the genitourinary system.